Angle's class II division 1 malocclusion, being the most commonly occuring type of malocclusion, is challenging to treat especially when there is an underlying skeletal discrepancy. Various fixed functional appliances have been developed over the years by different authors for correction of skeletal class II malocclusion due to retrognathic mandible. Among the fixed functional appliances available for class II correction, Advansync2 (Ormco Co, Glendora, Calif) also known as molar to molar appliance has been used effectively in the recent past. It is a fixed tooth-born functional appliance with an advantage of allowing concurrent use of fixed orthodontic therapy. This facilitates reduction of the overall treatment duration. Two case reports of patients treated using the Advansync2 class II corrector has been presented along with the skeletal and dentoalveolar changes observed during the treatment. The effects observed were similar to most fixed functional appliances however the treatment duration was considerably reduced in all the cases.
Smile esthetics is a prime concern in contemporary orthodontic therapy. This case report is about a growing female patient with the inability to close the lips, vertical maxillary excess and hyperdivergent class II skeletal pattern. To enhance skeletal therapy benefits , differential intrusion of segments in the upper arch was required. Bilateral Bollard type miniplates were inserted on the infrazygomatic crest . The technique employed helped this patient avoid orthognathic surgery by allowing a complete upper arch intrusion, treating lip incompetence and causing counterclockwise movement of the mandible.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.